Tempus AI, Inc. Class A Common Stock Earnings

The next earnings date for Tempus AI, Inc. Class A Common Stock is July 31, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Tempus AI, Inc. Class A Common Stock Earnings

Report DateEstimated Earnings Per Share
07/31/2026$-0.14

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tempus AI, Inc. Class A Common Stock Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/05/2026After Market$-0.1332.82%
02/24/2026After Market$-0.045.21%
11/04/2025After Market$-0.1135.10%
08/08/2025Before Market$-0.2210.17%
05/06/2025After Market$-0.2416.98%
02/24/2025After Market$-0.1811.46%
11/04/2024After Market$-0.2520.15%
08/06/2024After Market$-1.47-120.52%

More About Tempus AI, Inc. Class A Common Stock

Country
USA
Full Time Employees
3,800

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Tempus AI, Inc. Class A Common Stock Earnings” Can Refer to the Tempus AI, Inc. Class A Common Stock Earnings Date

Some people say “Tempus AI, Inc. Class A Common Stock earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tempus AI, Inc. Class A Common Stock position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tempus AI, Inc. Class A Common Stock Stock on the Earnings Date

If you own Tempus AI, Inc. Class A Common Stock stock (TEM) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tempus AI, Inc. Class A Common Stock might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tempus AI, Inc. Class A Common Stock shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tempus AI, Inc. Class A Common Stock Earnings

You can contact us any time if you would like to ask questions about Tempus AI, Inc. Class A Common Stock earnings or anything else related to the stock market.